Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/28/22
End: 11/04/24
Due: 11/04/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy of AM712 in Patients with NAMD | NCT05345769 | AffaMed Therapeutics Limited | user2@example.com | None | 2022-04-28 | 2024-11-04 | 2025-11-04 | - | - | 2025-07-14 |